Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 51ºÚÁϳԹÏÍø Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background & Aim: The recent pandemic swine H1N1 influenza (2009) outbreak demonstrated that egg-based vaccine manufacturing
does not adequately respond to pandemic strains. Recent study has established an alternative for subunit vaccine by the use of the
recombinant. We try produced universal vaccine 4M2e-HA that can be produced in large scale in reasonable time.
Methods: In this study a recombinant 4xM2e-HA gene of influenza A virus was designed and expressed in MDCK cell which could
be secreted out of cells. Immunized mice with this protein induced both humoral and cellular response against influenza A virus.
Result: The immunized mice showed increased immunological indicators such as IFN-�³ and IL-2, IL-12, IL-4 and induced suitable
CTL response, also antibody against fusion protein can be neutralized both heterologous and homologues influenza virus.
Conclusion: These findings suggest that 4xM2e-rHA expression in MDCK cell may provide a new approach for developing a novel
universal vaccine that may protect not only specifically against a new circulating strains but is expected to protect broadly against
new virus strains possessing common epitopes with conserved sequences. The 4xM2e-rHA protein is a highly purified single protein
that might enhance tolerance against the antigen and allows administration of higher doses and produce stronger immunological
response and protection against the mentioned virus.